These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2625363)

  • 1. Prevalence of Erythema migrans Borreliosis in blood donors.
    Schmidt R; Gollmer E; Zunser R; Krüger J; Ackermann R
    Infusionstherapie; 1989 Dec; 16(6):248-51. PubMed ID: 2625363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations of Lyme borreliosis.
    Berger BW
    Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of blood donors and recipients for Borrelia burgdorferi antibodies: no evidence of B. burgdorferi infection transmitted by transfusion.
    Böhme M; Schwenecke S; Fuchs E; Wiebecke D; Karch H
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):204-7. PubMed ID: 1422081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 6. Complications of Lyme borreliosis.
    Cooke WD; Dattwyler RJ
    Annu Rev Med; 1992; 43():93-103. PubMed ID: 1580609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
    Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
    J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspective on Lyme borreliosis.
    Kaslow RA
    JAMA; 1992 Mar; 267(10):1381-3. PubMed ID: 1740862
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infections with Borrelia burgdorferi in Würzburg blood donors: antibody prevalence, clinical aspects and pathogen detection in antibody positive donors].
    Böhme M; Schembra J; Bocklage H; Schwenecke S; Fuchs E; Karch H; Wiebecke D
    Beitr Infusionsther; 1992; 30():96-9. PubMed ID: 1284778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of transmission of Borrelia burgdorferi by blood transfusion.
    Halkier-Sørensen L; Kragballe K; Nedergaard ST; Jørgensen J; Hansen K
    Lancet; 1990 Mar; 335(8688):550. PubMed ID: 1968566
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome.
    Kindstrand E
    Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lyme borreliosis with erythema chronicum migrans and Garin-Bujadoux-Bannwarth meningopolyneuritis].
    Berthold F; Trzopek HG; Steudtemann D; Schwesinger G
    Z Gesamte Inn Med; 1989 Nov; 44(21):658-60. PubMed ID: 2609703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serologic evaluation of occurrence in Poland of Lyme disease caused by infection with Borrelia burgdorferi].
    Tylewska-Wierzbanowska S; Kruszewska D
    Med Dosw Mikrobiol; 1993; 45(4):487-91. PubMed ID: 8189829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
    Breier F; Kunz G; Klade H; Stanek G; Aberer E
    Infection; 1996; 24(1):69-72. PubMed ID: 8852474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].
    Tschudi M
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1091-2. PubMed ID: 7939077
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis.
    Karlsson M; Stiernstedt G; Granström M; Asbrink E; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):169-77. PubMed ID: 2186910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.